Oramed Pharmaceuticals (ORMP) Change in Accured Expenses (2016 - 2026)
Oramed Pharmaceuticals (ORMP) posted Change in Accured Expenses of $149000.0 for Q1 2026, up 348.33% on a QoQ basis from -$60000.0 in Q1 2025, and up 348.33% year-over-year from $33234.2 in Q1 2025.
Oramed Pharmaceuticals (ORMP) Change in Accured Expenses (2016 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Change in Accured Expenses history runs 11 years deep, the most recent figure standing at $149000.0 for Q1 2026.
- Quarterly Change in Accured Expenses rose 348.33% year-over-year to $149000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $149000.0 (down 96.39% YoY) and the FY2025 annual result came in at -$60000.0, down 101.7% from the prior year.
- Change in Accured Expenses was $149000.0 for Q1 2026 at Oramed Pharmaceuticals, up from -$60000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $3.5 million in Q4 2024 and bottomed at -$2.2 million in Q4 2023.
- A 5-year average of $139100.0 and a median of $1500.0 in 2022 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 221400.0% in 2024, while the deepest fall reached 13420.0% in 2024.
- Oramed Pharmaceuticals' Change in Accured Expenses stood at $2000.0 in 2022, then sank by 111650.0% to -$2.2 million in 2023, then jumped by 257.96% to $3.5 million in 2024, then sank by 101.7% to -$60000.0 in 2025, then soared by 348.33% to $149000.0 in 2026.
- Business Quant data shows ORMP's Change in Accured Expenses at $149000.0 in Q1 2026, -$60000.0 in Q1 2025, and $3.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | 149,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 149,000.00 |
| Mar 31, 2026 | 149,000.00 |
| Mar 31, 2025 | -60,000.00 |
| Mar 31, 2025 | -60,000.00 |
| Dec 31, 2024 | 3.52 Mn |
| Dec 31, 2024 | 3.52 Mn |
| Sep 30, 2024 | -1.55 Mn |
| Sep 30, 2024 | -1.55 Mn |
| Jun 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 2.22 Mn |
| Mar 31, 2024 | -666,000.00 |
| Mar 31, 2024 | -666,000.00 |
| Dec 31, 2023 | -2.23 Mn |
| Dec 31, 2023 | -2.23 Mn |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 2,000.00 |